Novavax Inc (NVAX)

$6.86 +0.02 (0.29%)
Market Cap 1.07B
Revenue (ttm) 682.16M
Net Income (ttm) -187.50M
EPS (ttm) N/A
PE Ratio 2.73
Forward PE 2.74
Profit Margin -27.49%
Debt to Equity Ratio 0.00
Volume 2,080,200
Avg Vol 4,204,166
Day's Range N/A - N/A
Shares Out 162.50M
Stochastic %K 75%
Beta 2.30
Analysts Sell
Price Target $12.67

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 268 2000
Address:
700 Quince Orchard Road, Gaithersburg, United States
stockflippper
stockflippper Dec. 5 at 2:56 AM
$NVAX went through a major round of layoffs
2 · Reply
OneDollarBob
OneDollarBob Dec. 5 at 2:30 AM
$NVAX Does anyone know if the vaccine companies are speaking at the ACIP meeting tomorrow? I know we won’t hear from JJ, but I’m kind of afraid of how I might react if I hear Silvia’s voice.
1 · Reply
OneDollarBob
OneDollarBob Dec. 5 at 2:24 AM
$NVAX 53 million shares shorted. Only 100,000 shares available to borrow. Praying for some big news from the ACIP meeting tomorrow. I fear that if we are not differentiated from the criminal mRNA brothers, we might be done?
0 · Reply
JB9696
JB9696 Dec. 5 at 2:22 AM
$NVAX https://x.com/thechiefnerd/status/1996714025132892562?s=46&t=BPce-qeJbdLoEJcNYw2cKw
0 · Reply
Keystonefin
Keystonefin Dec. 5 at 2:22 AM
$NVAX looks like there will be more articles similar to this one will be coming about all the bad side effects of mRNA vaccines! if it were safe, they would not make you wait 30 minutes after the shot (those of you who took mRNA shot remember that, plus a day of suffering at home)! These are great opportunities for Novavax to speak out; free advertisement really if JJ can take advantage of them. https://www.nbcnews.com/news/amp/rcna247440
0 · Reply
littlegretti
littlegretti Dec. 5 at 2:17 AM
$NVAX I’m liking the way this is looking
0 · Reply
BigCheeze2014
BigCheeze2014 Dec. 5 at 1:18 AM
$NVAX I think all the mRNA vaccines will have a Black Box Warning and NVAX vaccine will not have such a warning. NVAX will be bought out by one of its competitors which make mRNA vaccines.
0 · Reply
Jeffmeister2005
Jeffmeister2005 Dec. 5 at 12:39 AM
$NVAX JJ doesn't care what Shah has to say.... Shah can just, Fuck Off.... Sell their shares, fuck off.... Too bad 4U Shah.... too Bad!!! JJ don't give a fuck.... why should he??? 🤣🤣🤣🤣🤣🤣🤣
0 · Reply
Paulchowda
Paulchowda Dec. 5 at 12:21 AM
$NVAX as mentioned we wait—WE WAIT🤬 WE WAIT🤬 WE WAIT 🤬WE WAIT🤬AND WAIT🤬 SOME MORE— SHOW JJ THE SOOR ENOUGH ALREADY!!! I’m not yelling the letters are small🤬
0 · Reply
Biotechlineup
Biotechlineup Dec. 5 at 12:06 AM
$NVAX we wait. Technically the slightest positive indicators are appearing. The 10 day ma flipped positive. Resistance level is 6.88 and 7.43 ( big one 200 day ma) . Until the share price crosses the 200 day ma with the 10 day ma following close behind don’t get excited. Only thing you have to look at , nothing else. That happens , means institutional buying.
0 · Reply
Latest News on NVAX
FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 3 days ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA PFE

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 3 days ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA PFE

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

Dec 1, 2025, 9:59 AM EST - 3 days ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

MRNA

Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 19, 2025, 2:33 PM EST - 15 days ago

Novavax, Inc. (NVAX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 4:41 PM EST - 22 days ago

Shah Capital pushes for Novavax sale, warns of proxy fight

Novavax to Participate in Jefferies London Healthcare Conference

Nov 12, 2025, 8:00 AM EST - 22 days ago

Novavax to Participate in Jefferies London Healthcare Conference

Novavax, Inc. (NVAX) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:26 PM EST - 4 weeks ago

Novavax, Inc. (NVAX) Q3 2025 Earnings Call Transcript

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025, 8:00 AM EST - 4 weeks ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Novavax raises annual revenue forecast on strength of vaccine deals

Nov 6, 2025, 7:58 AM EST - 4 weeks ago

Novavax raises annual revenue forecast on strength of vaccine deals

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Nov 4, 2025, 7:00 AM EST - 4 weeks ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 30, 2025, 8:00 AM EDT - 5 weeks ago

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 22, 2025, 7:00 AM EDT - 6 weeks ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Oct 14, 2025, 1:08 PM EDT - 7 weeks ago

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 14, 2025, 6:09 AM EDT - 7 weeks ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Oct 7, 2025, 7:00 AM EDT - 2 months ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Novavax Announces Progress on Sanofi Agreement

Sep 30, 2025, 9:01 AM EDT - 2 months ago

Novavax Announces Progress on Sanofi Agreement

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 2 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 2:10 PM EDT - 3 months ago

Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 4, 2025, 8:00 AM EDT - 3 months ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Novavax to Participate in the Cantor Global Healthcare Conference

Sep 3, 2025, 8:00 AM EDT - 3 months ago

Novavax to Participate in the Cantor Global Healthcare Conference

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 27, 2025, 3:07 PM EDT - 3 months ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Novavax Announces Convertible Debt Refinancing

Aug 21, 2025, 7:43 AM EDT - 3 months ago

Novavax Announces Convertible Debt Refinancing

Novavax (NVAX) Profit Jumps on Milestone

Aug 6, 2025, 5:13 PM EDT - 4 months ago

Novavax (NVAX) Profit Jumps on Milestone

Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 3:56 PM EDT - 4 months ago

Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:08 AM EDT - 4 months ago

Novavax beats quarterly revenue estimates on milestone payment

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Aug 6, 2025, 8:00 AM EDT - 4 months ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 30, 2025, 8:00 AM EDT - 4 months ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Jul 24, 2025, 11:02 AM EDT - 4 months ago

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jul 24, 2025, 8:00 AM EDT - 4 months ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet

Jul 11, 2025, 6:00 AM EDT - 5 months ago

2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet

CGC

Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Jun 11, 2025, 8:59 PM EDT - 6 months ago

Novavax, Inc. (NVAX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:11 AM EDT - 6 months ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 11, 2025, 7:00 AM EDT - 6 months ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Vaccine actions and policy positions under US Health Secretary Kennedy

Jun 10, 2025, 10:45 AM EDT - 6 months ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

Jun 10, 2025, 9:30 AM EDT - 6 months ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

Jun 10, 2025, 8:18 AM EDT - 6 months ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

Novavax to Participate in Upcoming Investor Conferences

May 29, 2025, 8:00 AM EDT - 6 months ago

Novavax to Participate in Upcoming Investor Conferences

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

May 21, 2025, 8:15 AM EDT - 7 months ago

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 20, 2025, 4:34 PM EDT - 7 months ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

May 19, 2025, 12:15 PM EDT - 7 months ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 9:27 AM EDT - 7 months ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:16 AM EDT - 7 months ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 19, 2025, 7:00 AM EDT - 7 months ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

FDA approves Novavax COVID vaccine with new conditions

May 17, 2025, 10:26 PM EDT - 7 months ago

FDA approves Novavax COVID vaccine with new conditions

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

May 14, 2025, 10:46 PM EDT - 7 months ago

Novavax, Inc. (NVAX) Presents at BofA Securities 2025 Health Care Conference (Transcript)

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

May 12, 2025, 12:45 PM EDT - 7 months ago

Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

May 8, 2025, 1:31 PM EDT - 7 months ago

COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why

Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:48 AM EDT - 7 months ago

Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

May 8, 2025, 11:12 AM EDT - 7 months ago

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

Novavax swings to profit on lower expenses related to COVID shots

May 8, 2025, 8:06 AM EDT - 7 months ago

Novavax swings to profit on lower expenses related to COVID shots

stockflippper
stockflippper Dec. 5 at 2:56 AM
$NVAX went through a major round of layoffs
2 · Reply
OneDollarBob
OneDollarBob Dec. 5 at 2:30 AM
$NVAX Does anyone know if the vaccine companies are speaking at the ACIP meeting tomorrow? I know we won’t hear from JJ, but I’m kind of afraid of how I might react if I hear Silvia’s voice.
1 · Reply
OneDollarBob
OneDollarBob Dec. 5 at 2:24 AM
$NVAX 53 million shares shorted. Only 100,000 shares available to borrow. Praying for some big news from the ACIP meeting tomorrow. I fear that if we are not differentiated from the criminal mRNA brothers, we might be done?
0 · Reply
JB9696
JB9696 Dec. 5 at 2:22 AM
$NVAX https://x.com/thechiefnerd/status/1996714025132892562?s=46&t=BPce-qeJbdLoEJcNYw2cKw
0 · Reply
Keystonefin
Keystonefin Dec. 5 at 2:22 AM
$NVAX looks like there will be more articles similar to this one will be coming about all the bad side effects of mRNA vaccines! if it were safe, they would not make you wait 30 minutes after the shot (those of you who took mRNA shot remember that, plus a day of suffering at home)! These are great opportunities for Novavax to speak out; free advertisement really if JJ can take advantage of them. https://www.nbcnews.com/news/amp/rcna247440
0 · Reply
littlegretti
littlegretti Dec. 5 at 2:17 AM
$NVAX I’m liking the way this is looking
0 · Reply
BigCheeze2014
BigCheeze2014 Dec. 5 at 1:18 AM
$NVAX I think all the mRNA vaccines will have a Black Box Warning and NVAX vaccine will not have such a warning. NVAX will be bought out by one of its competitors which make mRNA vaccines.
0 · Reply
Jeffmeister2005
Jeffmeister2005 Dec. 5 at 12:39 AM
$NVAX JJ doesn't care what Shah has to say.... Shah can just, Fuck Off.... Sell their shares, fuck off.... Too bad 4U Shah.... too Bad!!! JJ don't give a fuck.... why should he??? 🤣🤣🤣🤣🤣🤣🤣
0 · Reply
Paulchowda
Paulchowda Dec. 5 at 12:21 AM
$NVAX as mentioned we wait—WE WAIT🤬 WE WAIT🤬 WE WAIT 🤬WE WAIT🤬AND WAIT🤬 SOME MORE— SHOW JJ THE SOOR ENOUGH ALREADY!!! I’m not yelling the letters are small🤬
0 · Reply
Biotechlineup
Biotechlineup Dec. 5 at 12:06 AM
$NVAX we wait. Technically the slightest positive indicators are appearing. The 10 day ma flipped positive. Resistance level is 6.88 and 7.43 ( big one 200 day ma) . Until the share price crosses the 200 day ma with the 10 day ma following close behind don’t get excited. Only thing you have to look at , nothing else. That happens , means institutional buying.
0 · Reply
AverageTraders
AverageTraders Dec. 4 at 11:41 PM
What is happening to ticker SNSE now?! Looks like they are going to SQUEEZE ticker SNSE up next .. SNSE is breaking out like crazy.. Its insane what's going on in this market.. Looks like all eyes are going to SNSE now.. Squeeze on $NVAX $TSLA $AMD $SMX too
0 · Reply
Benroxx
Benroxx Dec. 4 at 11:37 PM
$NVAX
0 · Reply
Chelsea100
Chelsea100 Dec. 4 at 11:29 PM
$NVAX to quite…
0 · Reply
stockflippper
stockflippper Dec. 4 at 11:20 PM
$NVAX https://www.linkedin.com/posts/novavax_nationalinfluenzavaccinationweek-activity-7402421689139015683-WQdC?utm_medium=ios_app&rcm=ACoAAA1Fg3EBVwphYt6gk_MsXRZKOVVi2my79HA&utm_source=social_share_send&utm_campaign=copy_link
0 · Reply
Iightning
Iightning Dec. 4 at 10:59 PM
1ightning® Premium Options Alert (Actionable) Ticker: $NVAX Contract: Dec 19 $7C Entry: 0.28 Exit: 0.44 Return: +57.91% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Paulchowda
Paulchowda Dec. 4 at 10:54 PM
$NVAX Ready to blow my stack in a big way, F Christmas my favorite holiday,F Novavax my favorite underachieving morons on the planet, quite a long list won’t write🤬 🤬🤬🤬🤬
0 · Reply
Flowdollas
Flowdollas Dec. 4 at 10:53 PM
$NVAX Seems to me the FDA can't pull mRNA jabs so they will kill it in the media. They have the data and VAERS Marks was trying to hide. Now it appears the plan is to keep releasing tidbits they found in that data. Novavax has purposely been lumped in since Prasad can't find anything wrong with Novavax. Novavax should be inundating the media with Marketing & PR using these media hit pieces on mRNA as a way to control the narrative. Sanofi has said their not doing a campaign until fall 2026. That means for a year we need JJ to protect the Novavax brand against false narratives. If we have a year before Sanofi is more involved, JJ has to step up and do his job to protect the integrity of Novavax. Every time the FDA comes out with mRNA hit pieces Novavax should have PR ready to control the narrative. Novavax is being pummeled by false accusations and the FDA knows it. https://www.nbcnews.com/health/health-news/fda-covid-vaccines-children-deaths-rcna246437
3 · Reply
P38FTD
P38FTD Dec. 4 at 10:49 PM
$NVAX Sounds like Kennedy and Makary are stumped as to how find a solution re the PFI and MRNA respiratory vaccine failure and the lack of a solution. Maybe Peter Principle should send them over a Harry and David Holiday fruit basket special along with a Power Point presentation on his company’s vaccine value prop. Just trying to help solve a problem here. Certainly not my intention to be pushy or a feather ruffler.
0 · Reply
BeddyTear
BeddyTear Dec. 4 at 10:39 PM
$NVAX guys, real value of this stock, with latest er forecast is around 4.x - i know market sometimes is unpredictible but not here. This stock will be pounded in next months. You don’t hear anything from JJ, you will not see any BO. My frustration fuel tank is almost empty, so I treat it as lesson learned for future. Maybe SI is high but it’s not AMC or GME, we will not have thousands or maybe even milions of people which will buy those shares. MM are on win-win position, so probably also in next months SI will decrease without major SP movement. Be a man and forgot about it for now, if this ticker will hold on market, maybe for few years, after new developments you will get back your money. But not with this CEO and not with current setup.
1 · Reply
kwinters71
kwinters71 Dec. 4 at 10:21 PM
$NVAX started a hastag on X #firejohnjacobs
0 · Reply
chloeworld5
chloeworld5 Dec. 4 at 10:20 PM
$NVAX i didn't expect 2025 would end up with 6ish dollars. I can't belive John Jacobs lost so much opportunities this year. He should understand a concept of marketing, promotion, agency lobby, and customer communications. Things could have been very different in this year. He was too much quiet in this year. I hope he announces his resignation before 2026. We have waited more than enough time.
0 · Reply
BensonFuller
BensonFuller Dec. 4 at 10:07 PM
$NVAX John "Happy Talk/No Deal" Jacobs better not show up at another Fireside and talk about how he and his team are executing. The only thing he has executed is his shareholders. Saying that Novavax is "in discussions" for a deal is no longer acceptable given that they have been spouting this bullshit for over 6 months now. Hopefully Shah can push this dead company that has great science but horrid management into a sale.
1 · Reply